RT @NorthstarVent: Together with @Business_Docs we have a FREE online workshop to help business owners build a roadmap to growth. Wherever…Read More
RT @SuperNetworkNE: Are you a North East SME looking to supercharge your funding journey? Our Innovation Finance programme can support yo…Read More
Great opportunity for a Project Manager with @UniofNewcastle spin-out @DxGlyco #moreandbetterjobs #northeastjobs #researchcommercialisation #fromlabtolife #NorthernAcceleratorRead More
RT @AMLoBiosciences: @newcastlehelix Its a great example of ground-breaking laboratory science meeting commercial reality and bringing a so…Read More
Amazing news from one of the most recent #NorthernAccelerator spin-outs from @UniofNewcastleRead More
More great opportunities with @durham_uni spin-out @MagnitudeBio at @NETParkUK #moreandbetterjobs #northeastinnovation #northeastjobs #researchcommercialisation #fromlabtolifeRead More
Great opportunity with @durham_uni spin-out @MagnitudeBio at @NETParkUK #moreandbetterjobs #northeastjobs #fromlabtolifeRead More
RT @MagnitudeBio: We're looking for a C. elegans researcher to join our team.Read More
RT @durham_uni: We’re so excited to welcome Professor Karen O’Brien to Durham! Following a competitive international recruitment process, P…Read More
Grab a cuppa and take in @GUVenturing focus feature on why the time is now for the North, and how Northern Accelerator is creating a joined up ecosystem for our region's spin-outs #northernaccelerator #northeastinnovation #fromlabtolifeRead More
To date we have
CEOs placed in start ups
Atelerix was the first Northern Accelerator spin-out, with CEO Dr Mick McLean recruited through the project’s ‘Execs into Business’ programme.
This Durham University spin-out is helping companies discover and develop new age-related treatments faster.
Healthcare experts and collaborators at Sunderland have been awarded funding of almost £50,000 from Northern Accelerator to develop a drug for the pre-clinical proof-of-concept stage over the next eight months
This innovative device could revolutionise the way we diagnose diseases, such as the newly emerged strain of coronavirus, COVID-19. To date, systems that diagnose from breath sampling have not proven to be reliable enough due to contamination, sample loss and variability issues.
gliff.ai is an innovative artificial intelligence (AI) company with ambitious plans to treble their staff headcount, expand into international export markets and secure multi-million-pound investment over the coming year.
Professor Kataky’s innovative work with biofilms to control the formation and spread of bacteria will make a real-world impact in the form of smart bandage technology. This can reduce reliance on antibiotics and improve patient outcomes, by reducing the risk of disease and infection when treating wounds.
Professor Che Connon is a serial academic entrepreneur, spinning out three companies from Newcastle University and bridging the gap between academia and private enterprise.
Growing up in North-Eastern Italy, Martina had a passion for STEM from a very young age.